An initial cohort of 15 patients has reached the two-year mark in an ongoing clinical trial for a posterior dynamic stabilization device designed to support an injured or degenerative spine without eliminating motion, according a release from the maker, Applied Spine Technologies.
The company added that the Stabilimax Dynamic Spine Stabilization System has also received FDA permission to resume a multi-center, randomized, controlled clinical trial, comparing posterior dynamic stabilization with the system to traditional spinal fusion stabilization to treat degenerative lumbar spinal stenosis.
The company has enrolled more than 100 patients in the trials to date.
Read the release about the Applied Spine posterior dynamic stabilization device.
From leadership shuffles and product debuts, here are eight key updates from spine and orthopedic devicemakers since April 9. 1.…
Interim data from Spineart’s Baguera-C investigational device study found the disc, in two-level cases, meets the threshold for a non-inferiority…
Spinal Simplicity’s Minuteman G5 device was used for the first time in Dubai, United Arab Emirates, according to an April…
Comments are closed.